Egg cases from Cal-Maine Foods, Inc. await delivery by Mississippi Department of Agriculture and Commerce employees to several hundred families, along with more than 1,400 boxes of meat products from Merchants Foodservice and 2,200 gallons of milk from Borden Dairy, at the Mississippi State Fairgrounds in Jackson, Mississippi, August 7, 2020.
Rogelio V. Solis | AP
Check out the companies making headlines after the bell on Tuesday:
Cal-Maine Foods – Cal-Maine Foods reported a surprising profit in the second fiscal quarter, raising shares by more than 2% after hours. The company reported earnings per share of 25 cents and revenue of $ 347.3 million. Analysts surveyed by FactSet had expected a loss of 8 cents before participation on revenue of $ 333.5 million. Sales of a dozen of the company’s eggs grew 4.6% on a year-over-year basis.
Myriad Genetics – The biotechnology company’s shares have risen almost 2% with news that Myriad will explore “strategic alternatives” for its autoimmune businesses. The company is also restructuring its international operations.
Smart Global Holdings – Smart Global reported better-than-expected fiscal earnings per share in the first quarter, raising the computer memory maker’s stock by 2.4%. Smart Global reported adjusted earnings per share of 78 cents, exceeding FactSet’s estimate of 70 cents per share. The company also released a better-than-expected revenue guidance for the current quarter.
Nektar Therapeutics – Nektar’s shares fell about 1% after the company announced that Dr. Brian Kotzin will take over as interim medical director, effective immediately, replacing the current CMO Wei Lin.